Neisseria gonorrhoeae

Year	Number tested	Ceftriaxone				Cefixime				Mosaic penA gene present		Ciprofloxacin				Spectinomycin				Azithromycin
		S	%	R	%	S	%	R	%	Number	%	S	%	R	%	S	%	R	%	S	%	R	%
2010	947	947	100%	0	0%	946	99.9%	1	0.1%	7	0.7%	12	1.3%	918	96.9%	947	100%	0	0%	-		-
2011	1225	1225	100%	0	0%	1223	99.8%	2	0.2%	66	5.4%	20	1.6%	1193	97.4%	1225	100%	0	0%	925	75.5%	48	3.9%
2012	1149	1149	100%	0	0%	1135	98.8%	14	1.2%	179	15.6%	33	2.9%	1105	96.2%	1149	100%	0	0%	804	70.0%	48	4.2%
2013	1134	1133	99.9%	1	0.1%	1126	99.3%	8	0.7%	121	10.7%	58	5.1%	1062	93.7%	1134	100%	0	0%	938	82.7%	53	4.7%
2014	1048	1047	99.9%	1	0.1%	1046	99.8%	2	0.2%	83	7.9%	48	4.6%	973	92.8%	1048	100%	0	0%	876	83.6%	52	5.0%
2015	1122	1119	99.7%	3	0.3%	1115	99.4%	7	0.6%	135	12.0%	35	3.1%	1083	96.5%	1122	100%	0	0%	787	70.1%	104	9.3%
2016	1179	1179	100%	0	0%	1179	100%	0	0%	169	14.3%	57	4.8%	1113	94.4%	1179	100%	0	0%	936	79.4%	89	7.5%
2017	1272	1270	99.8%	2	0.2%	1263	99.3%	9	0.7%	185	14.5%	59	4.6%	1197	94.1%	1270	99.8%	2	0.2%	1064	83.6%	79	6.2%
2018	1208	1207	99.9%	1	0.1%	1204	99.7%	4	0.3%	151	12.5%	84	7.0%	1108	91.7%	1207	99.9%	1	0.1%	916	75.8%	108	8.9%
2019	1145	1138	99.4%	7	0.6%	1131	98.8%	14	1.2%	187	16.3%	55	4.8%	1052	91.9%	1145	100%	0	0%	1113	97.2%	32	2.8%
2020	1205	1203	99.8%	2	0.2%	1193	99.0%	12	1.0%	130	10.8%	44	3.7%	1147	95.2%	1205	100%	0	0%	1187	98.5%	18	1.5%
2021	1603	1603	100%	0	0%	1599	99.8%	4	0.2%	151	9.4%	294	18.3%	1296	80.8%	1603	100%	0	0%	1595	99.5%	8	0.5%
2022	1088	1086	99.8%	2	0.2%	1084	99.6%	4	0.4%	125	11.5%	234	21.5%	847	77.8%	1088	100%	0	0%	1080	99.3%	8	0.7%
2023	1270	1245	98.0%	25	2.0%	1233	97.1%	37	2.9%	187	14.7%	101	8.0%	1163	91.6%	1270	100%	0	0%	1234	97.2%	36	2.8%

Source: https://www.chp.gov.hk/en/statistics/data/10/641/695/3330.html

Remark: Categorization of azithromycin susceptibility has been revised in 2019 by the Clinical Laboratory Standards Institute, USA.

Download Neisseria gonorrhoeae (in CSV format)